Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Boucai

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Endocrinology|September 19, 2022
Editorial: Targeted therapy in advanced thyroid cancerLaura Boucai
Endocrinology and Metabolism Clinics of North America|July 27, 2025
An Update on Redifferentiation Therapy for Radioiodine Refractory Thyroid CancerLaura Boucai
The Journal of Clinical Endocrinology and Metabolism|December 9, 2017
Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of RecurrenceSona Shah, Laura Boucai
The Journal of Clinical Endocrinology and Metabolism|March 9, 2022
Letter to the Editor From Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer"Laura Boucai, R Michael Tuttle
Clinical Endocrinology|August 30, 2008
Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practiceLaura Boucai, Martin I Surks
The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Age- and race-based serum thyrotropin reference limitsMartin I Surks, Laura Boucai
Thyroid : Official Journal of the American Thyroid Association|February 15, 2020
American Thyroid Association Satellite Symposium: Personalized Approach to Thyroid Disorders, Friday, March 27, 2020, 1:00 PM-5:30 PM, Moscone Convention Center, San Francisco, CaliforniaLaura Boucai, Francesco S Celi
Current Diabetes Reports|October 16, 2012
Impact of hypoglycemia in hospitalized patientsMichelle Carey, Laura Boucai, Joel Zonszein
JAMA|February 6, 2024
Thyroid Cancer: A ReviewLaura Boucai, Mark Zafereo, Maria E Cabanillas
Cancers|September 14, 2024
Decision Variables for the Use of Radioactive Iodine in Patients with Thyroid Cancer at Intermediate Risk of RecurrenceSamantha K Newman, Armando Patrizio, Laura Boucai
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Endocrinology|September 19, 2022
Editorial: Targeted therapy in advanced thyroid cancerLaura Boucai
Endocrinology and Metabolism Clinics of North America|July 27, 2025
An Update on Redifferentiation Therapy for Radioiodine Refractory Thyroid CancerLaura Boucai
The Journal of Clinical Endocrinology and Metabolism|December 9, 2017
Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of RecurrenceSona Shah, Laura Boucai
The Journal of Clinical Endocrinology and Metabolism|March 9, 2022
Letter to the Editor From Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer"Laura Boucai, R Michael Tuttle
Clinical Endocrinology|August 30, 2008
Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practiceLaura Boucai, Martin I Surks
The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Age- and race-based serum thyrotropin reference limitsMartin I Surks, Laura Boucai
Thyroid : Official Journal of the American Thyroid Association|February 15, 2020
American Thyroid Association Satellite Symposium: Personalized Approach to Thyroid Disorders, Friday, March 27, 2020, 1:00 PM-5:30 PM, Moscone Convention Center, San Francisco, CaliforniaLaura Boucai, Francesco S Celi
Current Diabetes Reports|October 16, 2012
Impact of hypoglycemia in hospitalized patientsMichelle Carey, Laura Boucai, Joel Zonszein
JAMA|February 6, 2024
Thyroid Cancer: A ReviewLaura Boucai, Mark Zafereo, Maria E Cabanillas
Cancers|September 14, 2024
Decision Variables for the Use of Radioactive Iodine in Patients with Thyroid Cancer at Intermediate Risk of RecurrenceSamantha K Newman, Armando Patrizio, Laura Boucai
Pageof 6